Advertisement

Markers to predict the efficacy of bevacizumab in the treatment of metastatic colorectal cancer

Abstract

The identification of clinical, biochemical and molecular markers to predict or monitor the efficacy of bevacizumab represents a major point in the treatment of patients with metastatic colorectal cancer. Studies and genetic analyses have been conducted to identify a predictive biomarker of bevacizumab efficacy. However, genes of the angiogenic pathway and angiogenic biomarkers vary substantially, thereby causing interindividual differences that complicate the identification of predictors for anti-vascular endothelial growth factor drugs like bevacizumab. So, the current challenge in bevacizumab treatment is to find predictive markers and implement them in clinical practice. In this review we have summarized the potential candidate biomarkers that may have a role in identifying patients who benefit most from bevacizumab treatment.

Tumori 2014; 100(4): 370 - 376

Article Type: REVIEW

DOI:10.1700/1636.17888

Authors

Umut Varol, Ibrahim Yildiz, Tarik Salman, Bulent Karabulut, Ruchan Uslu

Article History

This article is available as full text PDF.

Download any of the following attachments:

Authors

  • Varol, Umut [PubMed] [Google Scholar]
    Medical Oncology Clinic, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey
  • Yildiz, Ibrahim [PubMed] [Google Scholar]
    Medical Oncology Clinic, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey
  • Salman, Tarik [PubMed] [Google Scholar]
    Medical Oncology Clinic, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey
  • Karabulut, Bulent [PubMed] [Google Scholar]
    Division of Medical Oncology, Tulay Aktas Oncology Hospital, School of Medicine, Ege Universit, Izmir, Turkey
  • Uslu, Ruchan [PubMed] [Google Scholar]
    Division of Medical Oncology, Tulay Aktas Oncology Hospital, School of Medicine, Ege Universit, Izmir, Turkey

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.